Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2019
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Aspirin (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Therapy, Combination (MeSH)
- Fibrinolytic Agents (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Rivaroxaban (MeSH)